Randomised clinical trial: tegoprazan, a novel potassium‐competitive acid blocker, or lansoprazole in the treatment of gastric ulcer

BACKGROUND: Tegoprazan is a novel potassium‐competitive acid blocker for the treatment of acid‐related disorders. AIMS: To assess whether tegoprazan is non‐inferior to lansoprazole in terms of efficacy and safety in patients with gastric ulcers. METHODS: In this phase 3, double‐blind, active control...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Aliment Pharmacol Ther
Main Authors: Cho, Yu Kyung, Choi, Myung‐Gyu, Choi, Suck Chei, Lee, Kee Myung, Kim, Tae Oh, Park, Soo‐Heon, Moon, Jeong Seop, Lim, Yun Jeong, Kang, Dae Hwan, Cheon, Gab Jin, Baik, Gwang Ho, Kim, Kyoung Oh, Cho, Kwang Bum, Jang, Jin Seok, Park, Jong‐Jae, Son, Byoung Kwan, Jung, Hye‐Kyung, Kim, Byung‐Wook, Kim, Sung Kuk, Lee, Soo Teik, Cha, Jae Myung, Kim, Ah Rong, Kim, Eun Ji, Park, Hyun Wook, Song, Geun Seog
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Randomised Clinical Trial
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7496685/
https://ncbi.nlm.nih.gov/pubmed/32701188
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.15865
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados